24 June 2021
GH Research PLC Announces Pricing of Initial Public Offering
12 April 2021
GH Research Announces Closing of $125 Million Oversubscribed Series B Financing
19 November 2020
GH Research Ltd. Announces Completion of Phase 1 Clinical Study with GH001 (5-Methoxy-N,N-Dimethyltryptamine) in Healthy Volunteers and Updates on Further Progress
GH Research is funded by multiple top-tier biopharmaceutical investment firms.